Belgian experience with direct acting antivirals in people who inject drugs

Clicks: 261
ID: 266044
2017
PWID, especially active users, are underserved for DAA treatment in real life in Belgium. Reimbursement criteria based on fibrosis stage make it difficult to treat PWID. Treatment adherence is similar in PWID and the general population, even in patients with active abuse. DAA were safe and effective …
Reference Key
r2017drugbelgian Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bielen R;Moreno C;Van Vlierberghe H;Bourgeois S;Mulkay JP;Vanwolleghem T;Verlinden W;Brixko C;Decaestecker J;De Galocsy C;Janssens F;Cool M;Van Overbeke L;Van Steenkiste C;D'heygere F;Cools W;Nevens F;Robaeys G;;
Journal Drug and alcohol dependence
Year 2017
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/28618285
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male aged middle aged Retrospective Studies Cohort Studies substance abuse hepatitis c / epidemiology* antiviral agents / therapeutic use* antiviral agents / pharmacology intravenous / epidemiology* pmid:28618285 doi:10.1016/j.drugalcdep.2017.04.003 rob bielen christophe moreno geert robaeys belgium / epidemiology hepacivirus / drug effects hepatitis c / drug therapy* imidazoles / pharmacology imidazoles / therapeutic use simeprevir / pharmacology simeprevir / therapeutic use sofosbuvir / pharmacology sofosbuvir / therapeutic use intravenous / drug therapy*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.